Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: A hypothesis

Journal of Neurogenetics

Volumn 25, Issue 4, 2011, Pages 195-200

  Wostyn, Peter ^a   Van Dam, Debby ^b   Audenaert, Kurt ^c   De Deyn, Peter Paul ^b,d  

^a PC Sint Amandus ^*  (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Alzheimer's disease; Aquaporin 1; Carbonic anhydrase II; Cerebrospinal fluid pressure; Cerebrospinal fluid production; Choroid plexus; Intracranial pressure; Na +, K + ATPase; SLC4A10

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ABSORPTION; AGING; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; GENETIC ANALYSIS; HUMAN; INTERSTITIAL FLUID; INTRACRANIAL PRESSURE; NORMOTENSIVE HYDROCEPHALUS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN STRUCTURE;

AGE OF ONSET; AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID; EPENDYMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SODIUM-BICARBONATE SYMPORTERS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 81555218170     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2011.620191     Document Type: Article

References (43)

1. Berdahl, J. P., & Allingham, R. R. (2010). Intracranial pressure and glaucoma. Curr Opin Ophthalmol, 21, 106-111.
2. Berdahl, J. P., Allingham, R. R., & Johnson, D. H. (2008a). Cerebrospinal fl uid pressure is decreased in primary openangle glaucoma. Ophthalmology, 115, 763-768.
3. Berdahl, J. P., Fautsch, M. P., Stinnett, S. S., & Allingham, R. R. (2008b). Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: A casecontrol study. Invest Ophthalmol Vis Sci, 49, 5412-5418.
4. Brown, P. D., Davies, S. L., Speake, T., & Millar, I. D. (2004). Molecular mechanisms of cerebrospinal fl uid production. Neuroscience, 129, 957-970.
5. Bullock, R., & Hammond, G. (2003). Realistic expectations: The management of severe Alzheimer disease. Alzheimer Dis Assoc Disord, 17(Suppl 3), S80-S85.
6. Christensen, B. C., Houseman, E. A., Marsit, C. J., Zheng, S., Wrensch, M. R., Wiemels, J. L., et al. (2009). Aging and environmental exposures alter tissue-specifi c DNA methylation dependent upon CpG island context. PLoS Genet, 5, e1000602.
7. De Quervain, D. J., Poirier, R., Wollmer, M. A., Grimaldi, L. M., Tsolaki, M., Streffer, J. R., et al. (2004). Glucocorticoidrelated genetic susceptibility for Alzheimer ' s disease. Hum Mol Genet, 13, 47-52.
8. Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., 3rd, Silverberg, G. D., Miller, M. C., et al. (2006). RAGE, LRP-1, and amyloid-beta protein in Alzheimer ' s disease. Acta Neuropathol, 112, 405-415.
9. Han, M. E., Kim, H. J., Lee, Y. S., Kim, D. H., Choi, J. T., Pan, C. S., et al. (2009). Regulation of cerebrospinal fl uid production by caffeine consumption. BMC Neurosci, 10, 110.
10. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifi es variants at CLU and PICALM associated with Alzheimer ' s disease. Nat Genet, 41, 1088-1093.
11. Jacobs, S., Ruusuvuori, E., Sipilä, S. T., Haapanen, A., Damkier, H. H., Kurth, I., et al. (2008). Mice with targeted Slc4a10 gene disruption have small brain ventricles and show reduced neuronal excitability. Proc Natl Acad Sci U S A, 105, 311-316.
12. Johanson, C. E., Duncan, J. A., 3rd, Klinge, P. M., Brinker, T., Stopa, E. G., & Silverberg, G. D. (2008). Multiplicity of cerebrospinal fl uid functions: New challenges in health and disease. Cerebrospinal Fluid Res, 5, 10.
13. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study dentifi es variants at CLU and CR1 associated with Alzheimer s disease. Nat Genet, 41, 1094-1099.
14. Liu, W., Liu, Y., Qin, X. J., Schmidt, S., Hauser, M. A., & Allingham, R. R. (2010). AQP1 and SLC4A10 as candidate genes for primary open-angle glaucoma. Mol Vis, 16 , 93-97.
15. Masseguin, C., LePanse, S., Corman, B., Verbavatz, J. M., & Gabrion, J. (2005). Aging affects choroidal proteins involved in CSF production in Sprague-Dawley rats. Neurobiol Aging, 26, 917-927.
16. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., et al. (2010). Decreased clearance of CNS beta-amyloid in Alzheimer s disease. Science, 330, 1774.
17. Oresković, D., & Klarica, M. (2010). The formation of cerebrospinal fl uid: Nearly a hundred years of interpretations and misinterpretations. Brain Res Rev, 64, 241-262.
18. Oshio, K., Watanabe, H., Song, Y., Verkman, A. S., & Manley, G. T. (2005). Reduced cerebrospinal fl uid production and intracranial pressure in mice lacking choroid plexus water channel aquaporin-1. FASEB J, 19, 76-78.
19. Ott, B. R., Cohen, R. A., Gongvatana, A., Okonkwo, O. C., Johanson, C. E., Stopa, E. G., et al. (2010). Brain ventricular volume and cerebrospinal fluid biomarkers ofAlzheimer s disease. J Alzheimers Dis, 20, 647-657.
20. Pericak-Vance, M. A., & Haines, J. L. (2009). Beyond proof of principle: New genes for Alzheimer s disease through collaboration. Lancet Neurol, 8, 977-979.
21. Ren, R., Jonas, J. B., Tian, G., Zhen, Y., Ma, K., Li, S., et al. (2010). Cerebrospinal fluid pressure in glaucoma: A prospective study. Ophthalmology, 117, 259-266.
22. Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003). Causative and susceptibility genes for Alzheimer s disease: A review. Brain Res Bull, 61, 1-24.
23. Selkoe, D. J. (2001). Alzheimer s disease: Genes, proteins, and therapy. Physiol Rev, 81, 741-766.
24. Serot, J. M., Bene, M. C., & Faure, G. C. (2003a). Choroid plexus, aging of the brain, and Alzheimer s disease. Front Biosci, 8, s515-s521.
25. Serot, J. M., Bene, M. C., & Faure, G. C. (2003b). Normalpressure hydrocephalus and Alzheimer disease. J Neurosurg, 99, 797 - 798; author reply 798-799.
26. Serot, J. M., Bene, M. C., Foliguet, B., & Faure, G. C. (2000). Morphological alterations of the choroid plexus in late-onset Alzheimer' s disease. Acta Neuropathol (Berl), 99, 105-108.
27. Silverberg, G. D. (2004). Normal pressure hydrocephalus (NPH): Ischaemia, CSF stagnation or both. Brain, 127, 947-948.
28. Silverberg, G. D., Heit, G., Huhn, S., Jaffe, R. A., Chang, S. D., Bronte-Stewart, H., et al. (2001). The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer s type. Neurology, 57 , 1763-1766.
29. Silverberg, G. D., Huhn, S., Jaffe, R. A., Chang, S. D., Saul, T., Heit, G., et al. (2002a). Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg, 97 , 1271-1275.
30. Silverberg, G. D., Levinthal, E., Sullivan, E. V., Bloch, D. A., Chang, S. D., Leverenz, J., et al. (2002b). Assessment of low-fl ow CSF drainage as a treatment for AD: Results of a randomized pilot study. Neurology, 59, 1139-1145.
31. Silverberg, G., Mayo, M., Saul, T., Fellmann, J., & McGuire, D. (2006). Elevated cerebrospinal fluid pressure in patients with Alzheimer s disease. Cerebrospinal Fluid Res, 3, 7.
32. Silverberg, G. D., Mayo, M., Saul, T., Rubenstein, E., & McGuire, D. (2003). Alzheimer s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol, 2, 506-511.
33. Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., et al. (2010a). Amyloid effl ux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol, 69, 1034-1043.
34. Silverberg, G. D., Miller, M. C., Machan, J. T., Johanson, C. E., Caralopoulos, I. N., Pascale, C. L., et al. (2010b). Amyloid and Tau accumulate in the brains of aged hydrocephalic rats. Brain Res, 1317, 286-296.
35. Silverberg, G. D., Miller, M. C., Messier, A. A., Majmudar, S., Machan, J.T., Donahue, J. E., et al. (2010c). Amyloid deposition and infl ux transporter expression at the bloodbrain barrier increase in normal aging. J Neuropathol Exp Neurol, 69, 98-108.
36. Sleegers, K., Lambert, J. C., Bertram, L., Cruts, M., Amouyel, P., & Van Broeckhoven, C. (2010). The pursuit of susceptibility genes for Alzheimer s disease: Progress and prospects. Trends Genet, 26, 84-93.
37. Sloane, P. D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., et al. (2002). The public health impact of Alzheimer s disease, 2000 - 2050: Potential implication of treatment advances. Annu Rev Public Health, 23, 213-231.
38. Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., et al. (2006). Hypoxia facilitates Alzheimer s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A, 103, 18727-18732.
39. Thakur, M. K. (2000). Alzheimer s disease - a challenge in the new millennium. Curr Sci, 79, 101-108.
40. van Es, M. A., & van den Berg, L. H. (2009). Alzheimer s disease beyond APOE. Nat Genet, 41, 1047-1048.
41. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2008). Alzheimer s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin Neurol Neurosurg, 110, 101-109.
42. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2009a). Alzheimer s disease and glaucoma: Is there a causal relationship? Br J Ophthalmol, 93, 1557-1559.
43. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2009b). More advanced Alzheimer s disease may be associated with a decrease in cerebrospinal fluid pressure. Cerebrospinal Fluid Res, 6, 14.